Characterization of Cardiac Electrophysiological Effects of Autonomic Neuromodulation

Part of paid clinical trials in Philadelphia, Pennsylvania.

Sponsor
University of Pennsylvania
Study ID
NCT05377216
Phase
EARLY_PHASE1
Status
Recruiting
Apply to this trial

Conditions

  • Ventricular Tachycardia

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Stellate Ganglion Block — DRUG
    Left sided percutaneous stellate ganglion block

Study Details

Prospective cohort study evaluating the electrophysiologic and biochemical effects of stellate ganglion block in patients with ventricular tachycardia.

Key Dates

Start date
Sep 1, 2022
Status verified
Nov 2025
Primary completion
Jul 1, 2027
Completion
Jul 1, 2027

Study Design

Enrollment
20 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE

Arms

  • Experimental: Stellate ganglion block
    All subjects will undergo stellate ganglion block during their VT ablation procedure

Primary Outcome Measure

Ventricular Effective Refractory Period [ Time Frame: 30 minutes following stellate ganglion block ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Hospital of the University of PennsylvaniaPhiladelphiaPennsylvania19104
Timothy Markman, MD

Find similar trials in Philadelphia, PA

By research site
Hospital of the University of Pennsylvania· Philadelphia, PA

Related Studies